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Abstract
Background: In vivo assessment of inflammatory responses in the synovia of patients with MoM hip replacements
would be useful in the determination of the prognosis of the hip replacement. Aims of the study was to investigate
the correlation between cobalt and chrome levels in joint fluid with histopathological findings and the predictive
ability of metal ion levels for these findings.
Methods: In 163 revision surgeries (141 ASR THAs and 22 ASR hip resurfacings) joint fluid chrome and cobalt levels
were assessed and histological analysis of synovial tissues was performed. Histological analysis included assessment
of histiocytes, particle load, surface necrosis, lymphocyte cuffs and ALVAL-score.
Results: Surface necrosis correlated positively with cobalt levels both in both groups. Neither chrome nor cobalt
level had even fair discriminative ability to predict the presence or severity of any histological finding in the THA
group. In the hip resurfacing group, cobalt level had good discriminative ability to predict the presence of perivascular
lymphocytes and ALVAL-score of ≥7 whereas chrome had good discriminative ability to predict surface necrosis, metal
particle load and ALVAL-score of ≥7.
Conclusions: Measurement of metal ion levels following joint fluid aspirate offers no relevant information with regard
to histopathological findings in patients with large-diameter MoM THAs. Limited information may be gained from
assessment of joint fluid metal ion levels in patients with hip resurfacings, but disadvantages of an aspirate must be
carefully reviewed.
Keywords: Metal-on-metal, Adverse reaction to metal debris, Adverse soft tissue reaction, Joint fluid aspiration,
Histology, Synovial response
Background
Adverse reaction to metal debris (ARMD) continues to
be a major issue regarding survival of metal-on-metal
(MoM) hip arthroplasties [1–5]. Clinical findings of
ARMDARMD often include elevated blood metal ion
levels and pain or discomfort in the hip region [6–9].
Sometimes ARMDARMD may go without any clinical
findings. Especially in the modular MoM total hip re-
placements blood metal ion levels may be normal even
though clear ARMD is present in the revision surgery
[9]. These cases present a diagnostic dilemma. Further
issues arise from the fact that natural history of
ARMDARMD and pseudotumours, especially cystic
pseudotumours, is unknown to a greater extent.
Histopathological findings in failed MoM hip replace-
ments are well described. Patients diagnosed with
unexplained pain or ARMD tend to have specific histo-
pathological findings. One entity isALVAL (aseptic
lymphocyte-vasculitis associated lesions) which was ori-
ginally described by Willert and co-workers [10, 11].
ALVAL is not however a pathognomic finding in pa-
tients diagnosed with ARMD as shown by Hart et al.
[12]. Histiocyte dominated foreign body response is
sometimes seen in these patients without any signs of
ALVAL [8, 13]. Moreover another study suggests that
synovial necrosis with macrophage dominated inflam-
matory response might be an own entity in some failed
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MoM hip replacements [14]. In vivo assessment of in-
flammatory responses in the synovia of patients with
MoM hip replacements would therefore be very useful
in the determination of the prognosis of the hip re-
placement. No attempt, however, has been made to
examine the correlation of local concentration of metal,
ie. joint fluid metal ion level with histopathological
findings. Association between concentration and in-
flammatory response would indicate a threshold of con-
centration after which ALVAL response is evoked
instead of certain temporally associated cumulative
dose. Joint fluid metal ion levels may also be more sur-
rogate measurement of wear and metal ion release than
levels seen in the periphery (whole blood or serum).
Moreover, interpretation of blood metal ion levels is
erroneous in patients with bilateral MoM hip arthro-
plasties in situ. If metal ion levels in the joint fluid are
associated with the histopathological findings in the
periprosthetic tissues, measurement of these levels
would be a potentially effective tool to elucidate the
potential status of the implant. Currently, there is no
consensus regarding the role of joint fluid aspirations
in the diagnostics of ARMD diagnostics.
We aimed to study the etiological factors of synovial
inflammatory response and diagnostic utility of measure-
ment of metal ion levels after joint fluid aspiration. Pri-
mary aim of the study was to investigate whether there
is correlation between cobalt and chrome levels in joint
fluid with histopathological findings seen in the synovia
of patients with failed MoM hip replacement. Secondary
aim was to investigate the discriminative ability of joint
fluid metal ion levels predicting histopathological find-
ings in these patients.
Methods
This was a level II study with development of diagnostic
criteria on basis of consecutively operated patients with
applied gold standard (histological analysis of synovia re-
trieved in revision surgery). One thousand thirty-six
Anatomic Surface Replacement (ASR) THA (US Food and
Drug Administration, FDA, approved) or total hip resur-
facing arthroplasty (FDA not approved) (DePuy, Warsaw,
IN) were performed consecutively in 887 patients at our
institution between March 2004 and December 2009. After
the ASR recall in August 2010, we established an intensified
screening program for all patients with ASR MoM hips
[15]. All patients have undergone intense work-up includ-
ing clinical examination, whole blood cobalt and chrome
metal ion measurement and cross-sectional imaging [2].
Revision surgery was considered and suggested to patient if
(1) there was a clear pseudotumor (Imperial class 2A, 2B or
3) observed on cross-sectional imaging regardless of symp-
toms or whole blood metal ion levels; or (2) the patient had
elevated whole blood metal ion levels and hip symptoms
despite a normal finding on cross-sectional imaging; or (3)
the patient had a continuously symptomatic hip or progres-
sive symptoms regardless of imaging findings or metal ion
levels [12]. Symptoms included hip pain, discomfort, sense
of instability, and/or impaired function of the hip and
sounds from the hip (clacking, squeaking). Whole blood
metal ion levels were considered elevated if either chro-
mium or cobalt exceeded 5 ppb [16].
For the purposes of this study we identified all pa-
tients who have undergone revision surgery of the
MoM hip because of ARMD at our institution. Diag-
nosis of ARMD was based on perioperative findings.
Failure was classified as being secondary to ARMD if
the following, previously published criteria were met:
(1) there was either metallosis or macroscopic syno-
vitis in the hip joint; and/or (2) a pseudotumor was
found during revision; and/or (3) a moderate to high
amount of perivascular lymphocytes along with tissue
necrosis and/or fibrin deposition was seen in the his-
topathologic sample; and (4) perioperatively there was
no evidence of component loosening or periprosthetic
fracture [2]. Furthermore, infection was ruled out by
multiple (at least five) bacterial cultures obtained dur-
ing revision surgery.
Study group
Flow hart of the patient selection is shown in Fig. 1. In
total 256 hips have been revised due to ARMD. The
prevalence of ARMD was significantly higher in the
THR group compared to HR group (36.7 % vs. 11.8 %,
p < 0.001). Since October 2011, ARMDthere have been
185 revision operations in 174 patients due to ARMD.
Both all primary operations and revision operations of
these patients were performed at our institution. In
none of these 185 hips were there any signs of compo-
nent loosening perioperatively, neither were there posi-
tive findings in bacterial cultures, and macroscopic
findings of ARMD were present in each of these hips.
In 10 (4.7 %) hips, histological sample(s) were either
not taken, were inadequately retrieved or the sample
was not interpretable due to necrosis. Further, in 15
(11 %) hips the synovial fluid aspirate was either not
taken or not enough fluid was aspirated. This left 160 of
the 185 hips revised due to ARMD for analysis. In
addition, synovial aspirate was performed and synovia
sample analyzed in three hips of which one was revised
for aseptic loosening of the stem and two for unexplained
pain. The case with aseptic loosening had macroscopic
findings indicating also presence of ARMD. Two cases
with unexplained pain had only very mild metallotic stain-
ing and diagnosis of ARMD could not be readily done.
Thus, 163 hips were included in the study group, which
consisted of two subgroups: (1) The hip resurfacing group,
which included 22 hips (22 patients), and (2) the THA
Reito et al. BMC Musculoskeletal Disorders  (2015) 16:393 Page 2 of 12
group, which included 141 hips (132 patients). A written
informed consent was obtained from all patients partici-
pating in this study. We obtained permission to perform
this study from the ethics committee (Regional Ethics
Committee in The Pirkanmaa Hospital District’s Science
Centre) of the hospital district in which the study was
conducted.
Revisions and revision protocol
Six orthopaedic surgeons (including co-authors JP and
TP) performed revisions using posterior approach. Tech-
niques and implants used in these revision surgeries
have been described in detail in our recent study [17]. In
each revision operation, 1–5 samples of synovia and/or
pseudotumour tissue were taken for analysis. Primary
site of the sample was pseudotumour capsule, and if
such tissue was not present, sample was taken from the
pseudocapsule.
Joint fluid aspirate
Since October 2011, our perioperative MoM hip revision
protocol has involved joint fluid aspiration, which is
always taken before opening the deep fascia using a
standard 18–20 gauge needle connected to a Vacutainer
system (Becton, Dickinson and Company, Franklin
Lakes, New Jersey) and trace element tubes containing
sodium ethylene diamine tetraacetic acid (EDTA).
Measurement of metal ion levels
In the Finnish Institute for Occupational Health, stand-
ard operating procedures were established for Co and Cr
measurement using dynamic reaction cell inductively
coupled plasma (quadripole) mass spectrometry (Agilent
7500 cx, Agilent Technologies, Santa Clara, CA, USA).
The laboratory technicians were blinded to all clinical
outcomes. The samples were preserved in +6–+8 °C
prior to analysis. Samples were tested using detection
limits (DL) similar to those with whole blood sample.
DL for Cr was of 0.03 ppb and for Co of 0.3 ppb.
Histology
Each tissue sample was formalin fixed. The samples were
embedded in paraffin and several 10 μm microtome sec-
tions were made. Standard hematoxylin and eosin staining
was used. The sections were examined histologically
under normal light Nikon Eclipse 50i (Nikon Corporation,
Shinagawa, Tokyo, Japan). For investigational purposes all
available samples were retrospectively analyzed according
to principles described by Natu et al. [11]. Necrosis was
classified from Grade I to IV according to Natu et al. Natu
grading of necrosis is based to loss in synovial integrity
described by Davies et al. [18]. Davies Type 1 synovial sur-
face is intact epithelium. Type 2 synovial surface has loss
of cellular lining but without fibrin exudation. Type 3 sur-
face has both loss of synovial cell lining and fibrin exudate
Fig. 1 Flow chart of the study group selection
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is present. Type 4 synovial surface has gross disruption,
fissuring and fibrin exudates. In Natu Grade I necrosis
synovial consisted of only Davies Type 1 or 2. Grade II
consisted of Davies Type 3 or maximally 25 % of Type 4.
In Grade III necrosis surface consisted between 25 % and
75 % of Davies Type IV. In Grade IV surface showed more
than 75 % of Davies Type IV synovial loss. Lymphocytic
cuff thickness was calculated using graticule. An average
of five measurements was taken and graded as 0–3 (ab-
sent, 0.25 mm, 0.25 – 0.75 mm, >0.75 mm). Thickness of
histiocyte sheets was calculated and graded 0–3 (absent,
<1 mm, 1 – 2 mm, >2 mm). Particle load within histio-
cytes was graded as used in the assessment of iron decom-
position in liver cells [11]. In addition to these analyses
ALVAL-score was also assessed in each sample [13].
Statistics
Summary of statistical methods and their implemented in-
terpretation in relation research questions is shown in
Table 1. This was a Level III study. Due to retrospective
nature of our study sample size assessment was not per-
formed and instead the study was conducted including all
available hips for analyses. However, sample size calcula-
tion was done afterwards in a post-hoc manner in order
to investigate the power of our analysis as recommended
by the STROBE guidelines [19]. Receiver operator charac-
teristics (ROC) can be used to investigate the performance
of diagnostic continuous variable against binary classifier.
We considered area under curve (AUC) ≥ .75 in the ROC
curve as clinically useful test [20].
Distribution of joint fluid cobalt and chrome values
were highly skewed to left when inspecting histograms
thus implying violation of assumption of normality.
This was confirmed with Kolmogorov-Smirnov test
with Lilliefors correction (Cr: p = .8, Co: p = .8).
Mann–Whitney U -test was when comparing metal
ion levels in joint fluid when two groups were avail-
able. Kruskal-Wallis test was used with more than two
group comparisons. Spearman rank correlation was
used to study the association of ordinal observation
and joint fluid metal ion levels. Since the distribution
of ALVAL-score is known we treated it both categor-
ical and continuous variable and hence calculated both
Kruskal-Wallis statistics and correlation coefficient
when examining the association between ALVAL-
score and metal ion levels. ROC analysis was per-
formed to study the discriminative ability of cobalt
and chrome levels in joint fluid for each histological
observation. Due to lack of clinically relevant cut-off
values for observation with more than two classes (ie.
thickness of lymphocyte cuffs) AUC was calculated
using each possible subclass as threshold only if a
sample size criterion was fulfilled. Finally, sensitivity
and specificity was calculated and interpreted only if
AUC seen in the ROC curve was >0.75 and AUC was
also statistically significant as described earlier. In the
assessment of sensitivity and specificity Youden J -statistic
was used. This method offers the optimal cut-off value in-
dicating the threshold that maximizes the distance to the
identity (diagonal) line.
We performed post-hoc power calculation as de-
scribed by Obuchowski et al. [21]. When performing
sample size estimation for ROC analysis one hypotheses
that estimated AUC differs significantly (at level .05)
from AUC of 0.5 (ie. “better than coin flip”). Calculation
requires that significance level (Type I error) and study
power (1 – Type II error) are known. The former was
set to .05 (5 %) and the latter to .80 (80 %), which are
the most commonly used values. In addition, the ratio of
controls versus cases is required for the analyses. Since
our analysis involves several different study settings, one
specific set of required number of cases and control was
not calculated. Instead required number controls and
cases were calculated based on available kappa for each
ROC analysis separately. Graph implying the required
number cases and control was drawn separately for hip
resurfacings and THAs (Figs. 2 and 3). Interpretation of
sample size is assessed as follows: total number THAs
was 141. Hence sum of controls (hips without a desired
observation) and cases (hips with desired observation)
equals always 141 as shown in dual X-axis in Fig. 2. If
we had 20 hips with desired end-point (cases), there
would be 121 hips as controls. In order to have signifi-
cantly better discriminative ability with power of .80 for
AUC compared to AUC = 0.5 (“better than coin flip)”, an
AUC of 0.70 is needed in ROC analysis. As a general
rule as seen in the graphs, the higher the number of
cases and controls or the ratio of controls:cases, the
smaller AUC is required to be significantly better than
AUC = 0.5. Significance was set to .05. Statistical analysis
was performed with R 3.0.2 using pROC package.
Results
Comparison of demographical, clinical and histological
variables between groups is shown in Table 2. There was
significant correlation between joint fluid and whole
blood metal ion levels in both implant groups (Fig. 4).
Strength of correlation, however, was poorer in the THA
(Cr: ρ = .525, p < .001; Co: ρ = .487, p < .001) than in the
hip resurfacing group (Cr: ρ = .727, p < .001; Co: ρ = .602,
p < .001).
In the THA group cobalt levels correlated positively
with the surface necrosis whereas chrome levels did
not (Table 3). Median chrome and cobalt levels were
different across different grades of surface necrosis in
the hip resurfacing group. Associative statistics re-
vealed that both chrome and cobalt correlated posi-
tively with the severity of surface necrosis. No other
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differences of correlations were seen in the THA
group (Table 3). In the hip resurfacing group, there
were no hips with lymphocyte cuff of >0.25 mm, and
hence two group comparisons was used (Tables 2 and 3).
Hips without lymphocyte cuff had lower median chrome
and cobalt levels compared to hips with cuff thickness of
0–0.25 mm (Cr: 474 ppb vs. 119 ppb, Co: 466 ppb vs.
88 ppb). There was also a positive correlation with
lymphocyte cuff thickness and chrome and cobalt joint
fluid levels. Neither did ALVAL-score correlate with joint
fluid chrome or cobalt level in the THA group (Co: p = .2,
Cr: p = .6). In the hip resurfacings group, both joint fluid
chrome and cobalt correlated positively with ALVAL-
score (Co: p < .001, Effect size: ρ = .675; Cr: p = .001, Effect
size: ρ = .641) (Fig. 5).
Neither chrome nor cobalt level had even fair discrimina-
tive ability to predict the presence or severity of any histo-
logical finding in the THA group. Only one significant
AUC (> AUC= .5) was seen in the THA group (Tables 4
and 5). However, this AUC predicting ALVAL score of 5 or
higher was so low that it indicated poor discriminative abil-
ity. In the hip resurfacing group, several useful AUCs with
good or excellent discriminative ability were seen (Tables 4
and 5). In this group, cobalt level alone had good discrim-
inative ability to predict the presence of lymphocyte cuffs
(>0 mm), Grade II or more severe surface necrosis and
grade 1 or higher particle load. Both chrome and cobalt
level had good discriminative ability to predict ALVAL-
score of ≥7 (Table 5). There was not enough cases to use
ALVAL score of ≥8 or ≥9 as an end-point.
Chrome and cobalt levels in joint fluid had good
discriminative ability to predict five different histopatho-
logical findings, but only in the hip resurfacing group
(Tables 4 and 5). Values for best sensitivity and specifi-
city were assessed in these five cases (Fig. 6).
Discussion
Identification of ARMD is a challenging process. Al-
though a wide range of novel methods are available,
especially whole blood metal ion measurement and
cross-sectional imaging, interpretation of results ob-
tained by these methods presents a diagnostic di-
lemma in some cases. Extremities of findings do not
introduce a diagnostic problem: a large, thick walled
pseudotumour with atypical content or extremely ele-
vated blood metal ion levels are clear signs of poorly
functioning MoM hip. However there is a wide range
of findings, e.g. slightly elevated blood metal ions and/
or small cystic pseudotumour seen in cross-sectional
imaging, that present a diagnostic problem. Correl-
ation of histopathological findings with bearing wear
and tissue metal content have been reported earlier
Fig. 2 Interpretation of required sample size in order to have significant AUC at level .05 with power .80 with 141 hips in the THA group
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[22, 23]. This kind of quantitative data is however
obtained only after revision operation. Whole blood
metal ion levels has been proposed being a surrogate
measurement for bearing and hardware wear but
results with regard to this topic is very controversial
[24]. Both total hardware wear and tissue metal con-
tent are matters of a cumulative dose. There are no
current recommendations on how to interpret the
results of joint fluid metal ion measurements. There
is also relative paucity in the current literature with
regard to usefulness of joint fluid metal ion
measurements.
We acknowledge some limitations in our study. First,
there may be selection bias in our material. All except
three of our patients were diagnosed with ARMD indicat-
ing that there was lack of hips with unresponsive syno-
vium (e.g. patients revised for periprosthetic fracture or
implant loosening). Including such hips would have in-
creased the strength of our study, since all hips in our
study group had some histopathological findings. On the
other hand, hips with presumably unresponsive synovia
are not usually scheduled to undergo synovial aspiration
and revision surgery, and therefore our study group is a
good sample of clinically relevant hips. Second, our study
group does not directly reflect the population that
normally undergoes synovial aspiration as part of diagnos-
tic work-up for unexplained pain or for suspected ARMD.
Instead, all of our patients had already been listed for
Fig. 3 Interpretation of required sample size in order to have significant AUC at level .05 with power .80 with 22 hips in the hip
resurfacing group
Table 1 Scheme of methods of present study
Research question Statistical method Outcome




Higher value of significant coefficient indicates
higher association with metal ion levels and
histological findings
2) Do cobalt and chrome levels in joint offer good or
excellent discriminative ability predicting histological
findings?
Value and significance of AUC in
ROC curve using Obuchowski method
AUC of >0.75 indicates good or excellent AUC.
Sample size criterion must be met to produce
significant AUC
3) What is the sensitivity and specificity of optimal
cut-off value for chrome and cobalt levels predicting
histopathological findings?
Youden J -statistic Produces optimal threshold (or cut-off) value defined
as maximal distance from ROC curve to diagonal line
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Fig. 4 Scatter plots of joint fluid versus WB metal ion levels. a Scatter plot of joint fluid cobalt versus WB cobalt in THAs. b Scatter plot of joint
fluid chrome versus WB chrome in THRs. c Scatter plot of joint fluid cobalt versus WB cobalt in hip resurfacings. d Scatter plot of joint fluid
chrome versus WB chrome in hip resurfacings
Fig. 5 Scatter plot of ALVAL-score versus joint fluid metal ion levels. a Scatter plot of cobalt level in joint fluid versus ALVAL-score in the THA
group. b Scatter plot of chrome level in joint fluid versus ALVAL-score in the hip resurfacing group
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revision. However, collecting our samples perioperatively
enabled us to have optimal circumstances for a good and
representative fluid aspirate. Third, perioperative joint as-
piration was not used in the early revisions. This presents
a selection bias in the study analyses. Our study cohort
may lack the most severe cases of ARMD assuming they
had undergone revision surgery prior to utilizing routine
joint aspiration procedure. However, the cause of this bias
cannot be reliably assessed since the association between
wear and histopathology is not clearly established. Finally,
samples obtained from soft tissues perioperatively might
not represent the overall response of the synovia. It is not
known to what extent one sample of synovia present the
actual type of histopathology in each case. Several samples
would minimize this variation but this approach has prac-
tical limitations since tissue preservation is important dur-
ing revision surgery. Furthermore, there might be
considerable variation of cell counts among different
sections from same sample. However we think that this
sampling bias is reduced significantly due to large group
of cases.
Several authors have reported joint fluid metal ion
levels in failed MoM hip replacements [8, 25, 26]. Kwon
et al. compared joint fluid metal ion levels in five pa-
tients with pseudotumour and 13 patients without one
[25]. There was practically no overlapping in metal ion
levels. Co levels ranged between 206–1802 in patients
with pseudotumour compared to range of 1.0–158 ppb
in patients without a pseudotumour. Respective Cr
values were 221–1322 ppb and 3–230 ppb. As so Co
level of >206 ppb and Cr level >221 ppb had very high
sensitivity and specificity for predicting the presence of a
pseudotumour. Majority of pseudotumours in that study
were cystic ones, which are not necessarily always re-
lated to ARMD. Cystic fluid collections are also seen in
non-MoM hip replacements [27]. Interestingly, however,
threshold levels seen in the study by Kwon et al. are
below our threshold values for adverse synovial
Fig. 6 ROC curve and best threshold with corresponding value for sensitivity and specificity for each outcome with significant AUC of > .75 in the
hip resurfacing group. a Joint fluid Co and Cr level predicting ALVAL-score of 7 or higher. b Joint fluid Co level predicting presence of lymphocyte
cuffs. c Joint fluid Co predicting particle load graded 1–4. d Joint fluid Cr predicting grade III-IV surface necrosis
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Table 2 Demographics, metal ion levels and frequencies of histological findings distributed by implant type
THA Hip resurfacing p-value
Demographic variables Age Mean (SD) 60.5 years (8.4) 50.4 years (8.6) <.001
Gender Males Females 72 69 12 10 .9
Metal ion levels Whole blood Median Co level (range) 11.9 ppb (1.1 – 139.9) 7.35 ppb (1 – 73) .03
Median Cr level (range) 3.4 ppb (0.7 – 61.6) 3.85 ppb (0.8 – 31) .4
Joint fluid Median Co level (range) 1291 ppb (36 – 19150) 271 ppb (40–5702) <.001
Median Cr level (range) 903 ppb (24 – 39160) 390 ppb (4 ppb – 7698) .004
Histological observations Lymphocyte cuff thickness Absent 50 10 .3
<0.25 mm 81 12
0.25 – 0.75 mm 10 -
Histiocyte sheet thickness Absent 4 - .4
<1 mm 108 18
1–2 mm 24 2
>2 mm 5 2
Surface necrosis Grade I 7 9 <.001
Grade II 34 4
Grade III 38 7
Grade IV 62 2
Particle load Grade 0 28 4 .6
Grade 1 25 5
Grade 2 37 3
Grade 3 36 6













responses. As a novel finding, we found that when joint
fluid ion levels exceed the threshold levels established by
Kwon et al. the possibility of synovial necrosis and
ALVAL-score >7 becomes more likely, possible indicat-
ing presence of ALVAL response in the synovia and
mixed/solid pseudotumour. If progression of ARMD
were this straightforward, assessment of joint fluid metal
ion levels would be of great relevance.
Both in the hip resurfacing and in the THA groups,
severe surface necrosis was associated to high cobalt
levels in the joint fluid. This might imply a direct cyto-
toxic effect of cobalt ions as proposed by Mahendra
et al. [14]. Interestingly, we observed higher metal ion
levels in hips with lymphocyte cuffs in the hip resur-
facing group. This result concurs with Lohmann et al.
who stated that perivascular lymphocyte infiltration was
more prevalent in hips with high tissue metal content
[23]. Since necrosis, lymphocyte cuffs and loss in cell
structure is characteristic for severe ALVAL, this result
suggest that ALVAL might be a dose-dependent finding,
at least in patients with hip resurfacings. It also brings
up an important question: does hypersensitivity or metal
allergy truly exist. This issue certainly warrants further
research. It is, however, unclear why perivascular lym-
phocytes had no association with metal ion levels in the
THA group. Since only necrosis was associated to cobalt
ion levels in the joint fluid of patients with failed THA, a
direct cytotoxic effect might be more prevalent response
in this group. Other authors have previously suggested
that debris originating from the taper might be more toxic
than that originating from the bearing surface [28]. Our
results indirectly support this hypothesis.
In the hip resurfacing group, sensitivity and specificity
of cobalt and chrome levels in joint fluid for predicting
five different histological finding was relatively high.
These results suggest that the assessment of metal ion
levels from the joint fluid may be a useful clinical tool in
patients with symptomatic hip resurfacings, or in such
patients with slightly elevated blood metal ions. Assess-
ment of joint fluid metal ion levels and synovial inflam-
matory response would be especially useful, if a patient
with hip resurfacing has elevated blood metal ions or
hip symptoms, but no pseudotumor is seen in cross-
sectional imaging. In such cases, joint fluid metal ion
levels may give additional information on the synovial
response to metal debris. Especially low synovial metal
ion levels can confirm that there is no synovial response
in that hip. Another situation, where joint fluid metal
ion assessment can be useful, is when an asymptomatic
patient with bilateral MoM hips has markedly elevated
blood metal ions. In such situation, especially in the ab-
sence of any findings in cross-sectional imaging, joint
fluid aspirate may help in identifying, whether only one
or both of the hips are excessively producing metal



















>0 mm .549 .476 .817 .871a
>0.25 mm .538 .623 n/a n/a
Histiocyte
cuff thickness
>0 mm .586 .467 n/a n/a
≥1 mm .523 .606 .736 .687
Surface
necrosis
Grade II-IV .551 .688 .709 .829a
Grade III-IV .529 .621 .820 .807
Grade IV .638 .582 .85 .95
Particle load Grade 1–4 .536 .618 .638 .895a
Grade 2–4 .492 .571 .552 .625
Grade 3–4 .480 .489 .495 .551
Grade 4 .496 .504 .588 .677
n/a assessment of AUC not possible due to inadequate number of controls
and cases, see Table 1. a = significantly different from AUC = .5, see Figs. 2
and 3


















≥4 Low .633 .649 .823 .867
≥5 Moderate .709a .620 .829 .821
≥6 .511 .593 .813 .781
≥7 .546 .479 .867a .852a
≥8 .575 .510 n/a n/a
≥9 High .597 .478 n/a n/a
n/a assessment of AUC not possible due to inadequate number of controls
and cases, see Table 1. a = significantly different from AUC = .5, see Figs. 1
and 2
Table 3 Differences and correlations of synovial metal ion levels
in respective to ordinal histological observations
THA Hip resurfacing
Chrome Cobalt Chrome Cobalt






















Particle load Correlation p = .9 p = .2 p = .4 p = .7
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debris. It is important to note, however, that in our mater-
ial the values for the best threshold varied a lot, possibly
highlighting the independency of each histopathological
observation. Thus the interpretation of the joint fluid
levels must be done with caution especially within the
range from 109 ppb to 574 ppb.
Conclusion
We found that in patients with failed MoM hip replace-
ment the histopathological findings had relatively poor
correlation with the chrome and cobalt levels in the joint
fluid. This was especially true in the THA group. We
consider this a worrisome finding since this indicates
that non-bearing surface wear debris may have a direct
cytotoxic effect on synovia. In patients with hip resurfa-
cings, on the contrary, joint fluid metal ion levels had at
least a fair discriminative ability to predict surface necro-
sis and high ALVAL-score. This finding suggests a non-
linear dose-dependency for metal ions produced by the
bearing surface, ie. there may be a certain threshold for
these metal ions to launch a lymphocyte-dominated in-
flammatory response. Further studies with larger sample
size are required to confirm our preliminary results.
Based on these results, however, it seems to be clear that
routine measurement of joint fluid metal ion levels in
patients with MoM hips are neither useful nor advisable
in order to predict the synovial inflammatory responses.
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